Skip to content
20-F

Annual Report (Foreign)

MEDIWOUND LTD. MDWD

0001178913-25-000934

← back to feed
Filed
Mar 19, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Dec 31, 2024 10.79M sh
Current Liabilities restated FY 2024 · Dec 31, 2023 $18.13M
Total Liabilities FY 2024 · Dec 31, 2023 $34.86M
Current Assets FY 2024 · Dec 31, 2023 $49.7M
Total Assets FY 2024 · Dec 31, 2023 $66.46M
Shares Diluted FY 2024 · Dec 31, 2022 4.99M sh
Operating Cash Flow FY 2024 · Dec 31, 2022 −$11.89M
Eps Diluted FY 2024 · Dec 31, 2022 −$3.93
Eps Basic FY 2024 · Dec 31, 2022 −$3.93
Sga Expense FY 2024 · Dec 31, 2022 $6.92M
Rd Expense FY 2024 · Dec 31, 2022 $10.18M
Net Income FY 2024 · Dec 31, 2022 −$19.6M
Operating Income FY 2024 · Dec 31, 2022 −$8.35M
Gross Profit FY 2024 · Dec 31, 2022 $13.17M
Cost Of Revenue FY 2024 · Dec 31, 2022 $13.33M
Revenue FY 2024 · Dec 31, 2022 $26.5M
Cash And Equivalents FY 2024 · Dec 31, 2021 $11.05M
Stockholders Equity FY 2024 · Dec 31, 2021 −$4.58M